Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation

Haematologica. 2018 Jun;103(6):e264-e267. doi: 10.3324/haematol.2017.186304. Epub 2018 Feb 22.

Paul Saultier^{1

2}, Sarah Szepetowski³, Matthias Canault², Céline Falaise^{3

4

5}, Marjorie Poggi², Pierre Suchon^{2

4}, Vincent Barlogis^{3

6}, Gérard Michel^{3

6}, Stéphane Loyau⁷, Martine Jandrot-Perrus⁷, Jean-Claude Bordet^{8

9}, Marie-Christine Alessi^{2

4

5}, Hervé Chambost^{3

2}

¹ APHM, La Timone Children's Hospital, Department of pediatric hematology and oncology, Marseille, France paul.saultier@gmail.com.
² Aix Marseille Univ, INSERM, INRA, C2VN, France.
³ APHM, La Timone Children's Hospital, Department of pediatric hematology and oncology, Marseille, France.
⁴ APHM, CHU Timone, Laboratory of Hematology, Marseille, France.
⁵ APHM, CHU Timone, French national reference center for inherited platelet disorders (CRPP), Marseille, France.
⁶ APHM, La Timone Children's Hospital, French national reference center for primary immune deficiencies (CEREDIH), Marseille, France.
⁷ Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Univ Paris Diderot, Sorbonne Paris Cité, France.
⁸ HCL, Hôpital Cardiologique Louis Pradel, Unité d'Hémostase Biologique, Bron, France.
⁹ EAM 4609 Hémostase et cancer, Université Claude Bernard Lyon 1, France.

No abstract available

Publication types